Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | WSD0922 |
Synonyms | |
Therapy Description |
WSD0922 is an EGFR inhibitor with blood brain barrier penetration activity, which may lead to anti-tumor activity in EGFR mutant CNS tumor and brain metastasis (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1326). |